Figure 1. DAS28 scores were significantly improved in RA responders (n = 40) but not in RA non-responders (n = 20) after the combination methotrexate (MTX)+ leflunomide (LEF) therapy.

DAS28 values were compared between pre- and post-treatment in each RA responder (A) or non-responder (B).